Fructosamine oxidase assay: methods and materials
US6855511B2 · kind B2 · utility
13Cited by
8References
25Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 26, 2001 |
| Grant date | Feb 15, 2005 |
| Priority date | — |
| Expiry date | Mar 26, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/66
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods whereby, by reference to fructosamine oxidase activity in blood plasma of a patient or patients, the risk of diabetes associated vascular complications can be assessed, candidate fructosamine oxidase inhibitors and/or antagonists can be identified or tested and the inhibition and/or antagonism of the fructosamine oxidase inhibition and/or antagonism of a patient can be assessed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.